SPDR S&P Pharmaceuticals ETF (XPH) ETF
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 290.12M |
| Net Asset Value (NAV) | $41.15 |
| Options? | Yes |
| Total Holdings | 47 |
XPH Stock Chart More Charts
XPH Price/Volume Stats
| Current price | $41.11 |
| Prev. close | $41.13 |
| Day low | $40.24 |
| Day high | $41.17 |
| 50-day MA | $44.12 |
| 200-day MA | $44.26 |
| 52-week high | $49.97 |
| 52-week low | $38.71 |
| Volume | 73,600 |
| Avg. volume | 90,685 |
| Dividend yield | 0.59% |
XPH Top Holdings
| Symbol | Company | % of Total |
| MRK | Merck & Co. Inc. | 5.53% |
| LLY | Eli Lilly and Company | 5.41% |
| PFE | Pfizer Inc. | 5.17% |
| JNJ | Johnson & Johnson | 5.17% |
| ZTS | Zoetis Inc. Class A | 5.02% |
| JAZZ | Jazz Pharmaceuticals Plc | 4.35% |
| BMY | Bristol-Myers Squibb Company | 4.34% |
| PRGO | Perrigo Co. Plc | 4.2% |
| MYL | Mylan N.V. | 4.2% |
| AGN | Allergan plc | 4.08% |
XPH Returns
| 1-mo | -6.74% |
| 3-mo | -15.56% |
| 6-mo | -6.91% |
| 1-year | -3.95% |
| 3-year | -20.34% |
| 5-year | 5.46% |
| YTD | -5.22% |
| 2017 | 12.05% |
| 2016 | -23.20% |
| 2015 | -4.62% |
| 2014 | 29.52% |
| 2013 | 60.84% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||